Androstan-17-ol, 3,3-difluoro-, acetate, (5alpha,17beta)-

• CAT Number: M121703
• CAS Number: 1827-75-4
• Molecular Formula: C21H32F2O2
• Molecular Weight: 354.48
• Purity: ≥95%
• Storage: -20°C
• IUPAC Name: [(5S,8R,9S,10S,13S,14S,17S)-3,3-difluoro-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] acetate
• InChI: InChI=1S/C21H32F2O2/c1-13(24)25-18-7-6-16-15-5-4-14-12-21(22,23)11-10-19(14,2)17(15)8-9-20(16,18)3/h14-18H,4-12H2,1-3H3/t14-,15-,16-,17-,18-,19-,20-/m0/s1
• InChIKey: BUIQHUBDLNDWCY-RBZZARIASA-N
• SMILES: CC(=O)OC1CCC2C1(CCC3C2CCC4C3(CCC(C4)(F)F)C)C

Androstan-17-ol, 3,3-difluoro-, acetate, (5alpha,17beta)-（Cat No.:M121703） is a synthetic derivative of testosterone, a male sex hormone. It is characterized by the addition of two fluorine atoms at the 3rd carbon position in the A ring of the steroid structure. This modification enhances its stability and pharmacological properties. Androstan-17-ol, 3,3-difluoro-, acetate, (5alpha,17beta)- is used in research settings to study androgen receptor function and as a potential therapeutic agent for conditions such as androgen deficiency and certain types of breast cancer.